Weill Cornell Medicine

Researchers

• MGMoustafa Gabr

Running trials

• Recruiting

  Digital Mindfulness Meditation in Adolescents With Atopic Dermatitis

  NCT07746427· Weill Medical College of Cornell University· Source

• Not yet recruiting

  Modality Choice Before and After Failure for the Treatment of Painful Diabetic Neuropathy

  NCT07795593· Phase 4· University of Michigan· Source

• Recruiting

  Mobile Cognitive Behavioral Therapy in Early Stroke Recovery

  NCT07639606· Weill Medical College of Cornell University· Source

• Recruiting

  Bright Light Therapy in Patients With Melanoma or Non-small Cell Lung Cancer (NSCLC) Who Are Receiving First-Line Immune Checkpoint Blockade

  NCT07661966· Weill Medical College of Cornell University· Source

• Not yet recruiting

  Ovarian Cancer Liquid Biopsy for Early Assessment & Detection in Individuals With BRCA1/2 Pathogenic Variants

  NCT07764744· Weill Medical College of Cornell University· Source

• Not yet recruiting

  Metformin to Attenuate Progressive Respiratory Decline in Idiopathic Pulmonary Fibrosis

  NCT07520110· Phase 3· University of Massachusetts, Worcester· Source

• Recruiting

  A Study to Evaluate the Safety and Efficacy of JZP926 Capsule for the Treatment of Juvenile Myoclonic Epilepsy

  NCT07723963· Phase 2/3· Jazz Pharmaceuticals· Source

• Recruiting

  ReVeRA-301: Etripamil in Atrial Fibrillation Phase 3

  NCT06716021· Phase 3· Milestone Pharmaceuticals Inc.· Source

• Recruiting

  Biomarker-Guided Antidepressant Selection

  NCT07680140· Phase 4· Weill Medical College of Cornell University· Source

• Recruiting

  Neuromodulation of Mood Switch Circuitry in Bipolar Disorder

  NCT07680153· Phase 4· Weill Medical College of Cornell University· Source

• Recruiting

  APP-MNT: App-Enhanced Medical Nutrition Therapy on Glycemic Outcomes and Quality of Life

  NCT07773779· Weill Medical College of Cornell University· Source

• Recruiting

  Improving TRansitions ANd OutcomeS for Heart FailurE Patients in Home Health CaRe (I-TRANSFER-HF)

  NCT06118983· Weill Medical College of Cornell University· Source

• Recruiting

  PRE-EMPT: Prospective RandomizEd Evaluation and Management of Premature aTherosclerosis

  NCT07232069· Phase 3· Duke University· Source

• Recruiting

  Tirzepatide's Role in Postmenopausal HR+ Breast Cancer Survivors

  NCT07257484· Phase 4· Weill Medical College of Cornell University· Source

• Recruiting

  A Study of LY4152199 in Participants With Previously Treated B-cell Malignancies (BAF_FRontier-1 )

  NCT07101328· Phase 1· Eli Lilly and Company· Source

• Recruiting

  Quantifying New Heart Muscle Cells

  NCT06587165· Weill Medical College of Cornell University· Source

• Recruiting

  Study of INCA036978 in Participants With Myeloproliferative Neoplasms

  NCT07441694· Phase 1· Incyte Corporation· Source

• Recruiting

  Impact of Barostimulation on Hemodynamics in Adults With Heart Failure

  NCT07335510· Columbia University· Source

• Recruiting

  Continuous Dual Aspiration Technique With Zoom System for Stroke

  NCT07491952· Imperative Care, Inc.· Source

• Recruiting

  Stereotactic MRI-guided Focused Ultrasound Mesencephalotomy

  NCT07405645· University of Virginia· Source

• Recruiting

  The WiSE®-UP Study (The WiSE System Utilization & Performance Study)

  NCT07098858· EBR Systems, Inc.· Source

• Active, not recruiting

  A Study of Zasocitinib in Adults With Nonsegmental Vitiligo

  NCT07108283· Phase 2· Takeda· Source

• Enrolling by invitation

  Centralized Lung Cancer Screening Engagement in At-Risk Populations

  NCT07216144· Weill Medical College of Cornell University· Source

• Active, not recruiting

  Prospective Evaluation of the Pulse Biosciences nPulse™ Vybrance™ Percutaneous Electrode System

  NCT07287176· Pulse Biosciences, Inc.· Source

• Recruiting

  Investigational Trial to Evaluate XC001 Delivered Via an Cardiac Catheter in Subjects With Chronic Angina.

  NCT07048808· Phase 2· XyloCor Therapeutics, Inc.· Source

• Active, not recruiting

  A Double-blind Study Evaluating the Efficacy, Safety, and Tolerability of Zorevunersen in Patients With Dravet Syndrome

  NCT06872125· Phase 3· Stoke Therapeutics, Inc· Source

• Recruiting

  PRospective phenotypIng and Multi-omic Endotyping of Progressive Pulmonary Fibrosis

  NCT06855329· University of Massachusetts, Worcester· Source

• Recruiting

  Maintenance rTMS for Depression (Maitr-De)

  NCT06938841· University of California, San Diego· Source

• Recruiting

  Genetic Developmental and Epileptic Encephalopathy Natural History Study for Clinical Trial Readiness

  NCT07413211· Weill Medical College of Cornell University· Source

• Recruiting

  Mobile Cognitive Behavioral Therapy for Stroke

  NCT06689878· Weill Medical College of Cornell University· Source

• Recruiting

  Preoperative Radioimmunotherapy Versus Chemoimmunotherapy in NSCLC

  NCT06623656· Phase 2· Weill Medical College of Cornell University· Source

• Enrolling by invitation

  Utility of Random Biopsies in Patients With Inflammatory Bowel Disease

  NCT06560021· Abramson Cancer Center at Penn Medicine· Source

• Recruiting

  Trial in Arrhythmia Radioablation for Ventricular Tachycardia: Single Fraction vs Three Fractions

  NCT06743789· Weill Medical College of Cornell University· Source

• Active, not recruiting

  Evaluation of the Safety and Effectiveness of the CereVasc® eShunt® System in Normal Pressure Hydrocephalus

  NCT06498960· CereVasc Inc· Source

• Active, not recruiting

  Investigation of the BrioVAD System for the Treatment of Left Ventricular Heart Failure

  NCT06310031· BrioHealth Solutions, Inc.· Source

• Recruiting

  Pericardiotomy in Cardiac Surgery

  NCT06486636· Population Health Research Institute· Source

• Recruiting

  Real-world Evaluation of the HistoSonics Edison System for Treatment of Liver Tumors Across Multidisciplinary Users (BOOMBOX: Master Study)

  NCT06486454· HistoSonics, Inc.· Source

• Active, not recruiting

  A Study to Evaluate the Safety and Efficacy of Axatilimab in Combination With Ruxolitinib in Participants With Newly Diagnosed Chronic Graft-Versus-Host Disease

  NCT06388564· Phase 2· Incyte Corporation· Source

• Recruiting

  Testing the Role of Anti-fungal Therapy in Improving the Response to Therapies for Crohn's Disease

  NCT06274554· Phase 3· Weill Medical College of Cornell University· Source

• Recruiting

  Soquelitinib vs Standard of Care in Participants With Relapsed/Refractory Peripheral T-cell Lymphoma Not Otherwise Specified, Follicular Helper T-cell Lymphomas, or Systemic Anaplastic Large-cell Lymphoma

  NCT06561048· Phase 3· Corvus Pharmaceuticals, Inc.· Source

• Active, not recruiting

  A Study to Test the Safety, Tolerability, and Efficacy of an Antibody, REGN7999, Injected Under the Skin for the Treatment of Iron Overload in Adult Participants With Non-Transfusion Dependent β-thalassemia, Using MRI Scans to Measure Iron Levels in the Body

  NCT06421636· Phase 2· Regeneron Pharmaceuticals· Source

• Recruiting

  Digital Solutions to Reduce Maternal Morbidity and Mortality in Pregnant Refugee Women

  NCT06647511· Weill Medical College of Cornell University· Source

• Active, not recruiting

  Study to Evaluate the Effect on Obesity of QW Nimacimab and QW Nimacimab Co-administered With Semaglutide vs Placebo

  NCT06577090· Phase 2· Skye Bioscience, Inc.· Source

• Recruiting

  One-Month DAPT in CABG Patients

  NCT05997693· Phase 3· Weill Medical College of Cornell University· Source

• Active, not recruiting

  A Study of Upadacitinib in Adult Participants With Moderate-to-Severe Atopic Dermatitis and Inadequate Response to Dupilumab

  NCT06389136· Phase 3· AbbVie· Source

• Recruiting

  Reducing Obesity Using Social Ties Program

  NCT06335810· Weill Medical College of Cornell University· Source

• Recruiting

  A Preliminary Study for INFORMED

  NCT05585125· Phase 4· Weill Medical College of Cornell University· Source

• Active, not recruiting

  Sonocloud-9 in Association With Carboplatin Versus Standard-of-Care Chemotherapies (CCNU or TMZ) in Recurrent GBM

  NCT05902169· Phase 3· CarThera· Source

• Active, not recruiting

  GAE Using Embosphere Microspheres vs Corticosteroid Injections for Treatment of Symptomatic Knee OA (MOTION)

  NCT05818150· Merit Medical Systems, Inc.· Source

• Recruiting

  A Study to Evaluate INCB161734 in Participants With Advanced or Metastatic Solid Tumors With KRAS G12D Mutation

  NCT06179160· Phase 1· Incyte Corporation· Source

Showing 50 of 132.

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Heart failure7 recruiting
• Prostate cancer6 recruiting
• Coronary artery disease5 recruiting
• Depression5 recruiting
• Lung cancer5 recruiting
• Epilepsy4 recruiting
• Obesity4 recruiting
• Alzheimer disease3 recruiting
• Crohn's disease3 recruiting
• Metastatic breast cancer3 recruiting
• Parkinson disease3 recruiting
• Stroke3 recruiting
• Friedreich ataxia2 recruiting
• Idiopathic pulmonary fibrosis2 recruiting
• Type 2 diabetes2 recruiting
• Acute myeloid leukaemia1 recruiting
• Atopic dermatitis (eczema)1 recruiting
• Atrial fibrillation1 recruiting
• Barrett's oesophagus1 recruiting
• Bipolar disorder1 recruiting
• Bladder cancer1 recruiting
• Childhood cancers1 recruiting
• Chronic kidney disease1 recruiting
• Colorectal cancer1 recruiting
• Fatty liver disease (MASLD/MASH)1 recruiting
• Follicular lymphoma1 recruiting
• Head and neck cancer1 recruiting
• High blood pressure1 recruiting
• HIV1 recruiting
• Hypertrophic cardiomyopathy1 recruiting
• Liver and biliary tract cancer1 recruiting
• Liver cirrhosis1 recruiting
• Mantle cell lymphoma1 recruiting
• Melanoma1 recruiting
• Meningioma1 recruiting
• Migraine1 recruiting
• Multiple myeloma1 recruiting
• Myeloproliferative neoplasms1 recruiting
• Ovarian cancer1 recruiting
• Pancreatic cancer1 recruiting
• Polycystic kidney disease1 recruiting
• Spinal cord injury1 recruiting
• Type 1 diabetes1 recruiting
• Ulcerative colitis1 recruiting
• Ventricular tachycardia1 recruiting

Closed trials

• Terminated

  A Clinical Trial of CAP-002 Gene Therapy in Pediatric Patients With Syntaxin-Binding Protein 1 (STXBP1) Encephalopathy

  NCT06983158· Phase 1/2· Capsida Biotherapeutics, Inc.· Source

• Completed

  A Technology-based Psychosocial Intervention to Support Social Engagement and Well-being in Older Adults With HIV

  NCT06560970· Weill Medical College of Cornell University· Source

• Completed

  Developing a Communication Intervention for People With Memory Challenges and Their Care Partners

  NCT05143255· Weill Medical College of Cornell University· Source

• Completed

  Telehealth Group Counseling and Preventive Care for Women

  NCT06404515· Weill Medical College of Cornell University· Source

• Terminated

  The Effects of SAINT® Neuromodulation System on Explicit and Implicit Suicidal Cognition

  NCT03693105· Phase 2/3· Magnus Medical· Source

• Terminated

  SAINT for MDD in an Inpatient Setting Follow-on

  NCT06462820· Phase 2/3· Magnus Medical· Source

• Completed

  Data-driven SDM to Reduce Symptom Burden in AF

  NCT04993807· Columbia University· Source

• Completed

  N-of-1 for Beta-Blockers in Cardiac Amyloidosis

  NCT05019027· Phase 4· Weill Medical College of Cornell University· Source

• Terminated

  Randomized, Double-blind Study of Efficacy and Safety of Bexotegrast (PLN-74809) for Idiopathic Pulmonary Fibrosis

  NCT06097260· Phase 2· Pliant Therapeutics, Inc.· Source

• Terminated

  Study of MT-8421 as Monotherapy and in Combination With Nivolumab in Patients With Selected Advanced Solid Cancer Types

  NCT06034860· Phase 1· Molecular Templates, Inc.· Source

• Completed

  Early Parkinson's Disease Monotherapy With CVN424

  NCT06006247· Phase 2· Cerevance Beta, Inc.· Source

• Completed

  Intended to Determine the Effects of Seladelpar on Normalization of Alkaline Phosphatase Levels in Subjects With Primary Biliary Cholangitis (PBC)

  NCT06060665· Phase 3· Gilead Sciences· Source

• Completed

  Study of Oral Epigallocatechin-3-gallate (EGCG) in IPF Patients

  NCT05195918· Phase 1· Hal Chapman· Source

• Completed

  Use of a Screening Tool to Describe HIV-Related Cancer Burden and Patient Characteristics in the AMC

  NCT05510908· AIDS Malignancy Consortium· Source

• Completed

  A Study of Milvexian in Participants After a Recent Acute Coronary Syndrome

  NCT05754957· Phase 3· Janssen Research & Development, LLC· Source

• Withdrawn

  Ketogenic Diet in Patients With Untreated Low Tumor Burden Mantle Cell Lymphoma

  NCT04231734· Weill Medical College of Cornell University· Source

• Terminated

  A Safety, Tolerability and Efficacy Study of NC525 in Subjects With Advanced Myeloid Neoplasms

  NCT05787496· Phase 1· NextCure, Inc.· Source

• Completed

  Diabetes Care for Breast Cancer Patients

  NCT05565534· Weill Medical College of Cornell University· Source

• Completed

  3BNC117-LS and 10-1074-LS Plus N-803 (bNAb+N-803)

  NCT05245292· Phase 1· Rockefeller University· Source

• Completed

  Exploratory Ph 2A, Double-Blind, Placebo-Controlled Dose Escalation Study of Safety, Tolerability, PD, & PK of HU6 for Subjects With Obese HFpEF

  NCT05284617· Phase 2· Rivus Pharmaceuticals, Inc.· Source

• Completed

  A Double-blind Study to Evaluate the Safety of Glutamic Acid Decarboxylase Gene Transfer in Parkinson's Participants

  NCT05603312· Phase 1/2· MeiraGTx, LLC· Source

• Completed

  Telehealth Lifestyle Program for Black Adolescent Girls at Risk for Type 2 Diabetes

  NCT05396443· Cornell University· Source

• Completed

  The Effect of Simulation-based Training on Confidence and Competence in Obtaining Vitals in a Child With Autism

  NCT05288868· Weill Medical College of Cornell University· Source

• Terminated

  A Study of the Safety, Tolerability and Effectiveness of EZM0414 (IPN60210) Investigative Product in Participants With Relapsed/Refractory Multiple Myeloma and Relapsed/Refractory Diffuse Large B Cell Lymphoma

  NCT05121103· Phase 1· Epizyme, Inc.· Source

• Withdrawn

  Early Intervention With Acalabrutinib in Patients With High Risk CLL

  NCT04660045· Phase 2· Weill Medical College of Cornell University· Source

• Completed

  A Study of MGC018 in Combination With MGD019 in Participants With Advanced Solid Tumors

  NCT05293496· Phase 1· MacroGenics· Source

• Completed

  Pivotal Study of the NanoKnife System for the Ablation of Prostate Tissue

  NCT04972097· Angiodynamics, Inc.· Source

• Completed

  A Pilot Study to Determine Fructose Uptake by Primary Human Colorectal Tumors

  NCT05136092· Weill Medical College of Cornell University· Source

• Completed

  Paxalisib With a High Fat, Low Carb Diet and Metformin for Glioblastoma

  NCT05183204· Phase 2· Weill Medical College of Cornell University· Source

• Terminated

  Randomized Trial of Five or Two MRI-Guided Adaptive Radiotherapy Treatments for Prostate Cancer

  NCT04984343· Phase 2· Weill Medical College of Cornell University· Source

• Completed

  Walnuts and Colon Health (The WellNut Trial)

  NCT05195970· UConn Health· Source

• Terminated

  Evaluation of Ability to Detect Bowel Gas During Laparoscopic Right Colectomy With Intracorporeal Anastomosis

  NCT04964297· Weill Medical College of Cornell University· Source

• Completed

  Verification of Risk Assignment for Whole Chromosome Using SNP-based NIPT in Vanishing Twin Pregnancies

  NCT05004337· Natera, Inc.· Source

• Terminated

  A Trial With Chemotherapy, Immunotherapy, and Radiotherapy for Patients With Newly Diagnosed Stage IV Small Cell Lung Cancer

  NCT04951115· Phase 2· Weill Medical College of Cornell University· Source

• Completed

  Prostate Cancer - Comparative Outcomes of New Conceptual Paradigms for Treatment

  NCT04890314· Weill Medical College of Cornell University· Source

• Completed

  PReclude Infection EVEnts With No Prophylaxis Transperineal Biopsy

  NCT04843566· Weill Medical College of Cornell University· Source

• Terminated

  Cabozantinib in Patients With Metastatic Castrate Resistant Prostate Cancer (mCRPC)

  NCT04631744· Phase 2· Weill Medical College of Cornell University· Source

• Completed

  Cardiovascular Risk Assessment for Patients With Rheumatoid Arthritis Arthritis:

  NCT04488497· Weill Medical College of Cornell University· Source

• Completed

  Rimegepant in Moderate Plaque-type Psoriasis

  NCT04629950· Phase 2· Weill Medical College of Cornell University· Source

• Completed

  Prospective Treatment Efficacy in IPF Using Genotype for Nac Selection (PRECISIONS) Trial

  NCT04300920· Phase 3· Fernando J Martinez· Source

• Completed

  Hypertension, Brain Clearance, and Markers of Neurodegeneration

  NCT05785871· Weill Medical College of Cornell University· Source

• Completed

  Switch to Bictegravir/Emtricitabine/Tenofovir Alafenamide (BIC/F/TAF) After Renal Transplant

  NCT04530630· Phase 4· Weill Medical College of Cornell University· Source

• Completed

  Re-treatment 225Ac-J591 for mCRPC

  NCT04576871· Early phase 1· Weill Medical College of Cornell University· Source

• Completed

  Social Reward and Its Effect on Brain Functions in Psychotherapies for Mid- and Late-Life Depression

  NCT04487730· Weill Medical College of Cornell University· Source

• Terminated

  A Safety Study of SEA-TGT (SGN-TGT) in Advanced Cancer

  NCT04254107· Phase 1· Seagen Inc.· Source

• Completed

  Examining the Efficacy of Fecal Microbiota Transplantation (FMT) and Dietary Fiber in Patients With Ulcerative Colitis

  NCT03998488· Phase 2· Weill Medical College of Cornell University· Source

• Completed

  Trial of Parkinson's And Zoledronic Acid

  NCT03924414· Phase 4· California Pacific Medical Center Research Institute· Source

• Completed

  Gene Therapy for APOE4 Homozygote of Alzheimer's Disease

  NCT03634007· Phase 1/2· Lexeo Therapeutics· Source

• Terminated

  A Study of Ladiratuzumab Vedotin in Advanced Solid Tumors

  NCT04032704· Phase 2· Seagen Inc.· Source

• Completed

  A Trial of Talabostat (BXCL701) and Pembrolizumab in Participants With Metastatic Castrate-Resistant Prostate Cancer (mCRPC) Either Small Cell Neuroendocrine Prostate Cancer or Adenocarcinoma Phenotype

  NCT03910660· Phase 1/2· BioXcel Therapeutics Inc· Source

Showing 50 of 58.

Conditions

Diseases this institution publishes on or runs trials for.

• Stroke246 works · 3 trials
• Obesity207 works · 8 trials
• Alzheimer disease197 works · 6 trials
• Prostate cancer193 works · 23 trials
• HIV160 works · 6 trials
• Heart failure144 works · 11 trials
• Lung cancer138 works · 11 trials
• Type 2 diabetes102 works · 5 trials
• Melanoma95 works · 6 trials
• Bladder cancer79 works · 4 trials
• Colorectal cancer78 works · 6 trials
• Liver and biliary tract cancer76 works · 3 trials
• Tuberculosis70 works · 0 trials
• Atrial fibrillation69 works · 3 trials
• Kidney cancer65 works · 2 trials
• Metastatic breast cancer63 works · 4 trials
• Parkinson disease62 works · 10 trials
• Acute myeloid leukaemia57 works · 4 trials
• Pancreatic cancer49 works · 3 trials
• Epilepsy48 works · 7 trials
• Chronic kidney disease48 works · 1 trial
• Ovarian cancer48 works · 3 trials
• Sarcoma44 works · 1 trial
• Multiple myeloma42 works · 7 trials
• Osteoarthritis41 works · 1 trial
• Glioblastoma39 works · 4 trials
• Psoriasis36 works · 1 trial
• Fatty liver disease (MASLD/MASH)36 works · 1 trial
• Coronary artery disease35 works · 7 trials
• Diffuse large B-cell lymphoma33 works · 3 trials